Current position:Home >Product >
2(1H)-Isoquinolineacetamide, 3,4-dihydro-N-[2-[[[(4-methylphenyl)methyl]amino]carbonyl]phenyl]-
2(1H)-Isoquinolineacetamide, 3,4-dihydro-N-[2-[[[(4-methylphenyl)methyl]amino]carbonyl]phenyl]-(869474-87-3)
- Name: 2(1H)-Isoquinolineacetamide, 3,4-dihydro-N-[2-[[[(4-methylphenyl)methyl]amino]carbonyl]phenyl]-
- Synonyms:2(1H)-Isoquinolineacetamide, 3,4-dihydro-N-[2-[[[(4-methylphenyl)methyl]amino]carbonyl]phenyl]-;WAY-659989;gp120-α4β7 binding inhibitor 11;gp120-α4β7 binding inhibitor 11, 10 mM in DMSO
- Molecular Formula:C26H27N3O2
- Molecular Weight:413.51
- CAS Registry Number:869474-87-3
- EINECS:
- Melting Point:673.8±55.0 °C(Predicted)
- Water Solubility:
Other Product
- 869357-88-0/[1,1':2',1'':2'',1'''-Quaterphenyl]-4,4'''-diamine, N4,N4,N4''',N4'''-tetrakis(4-methylphenyl)-
- 869360-93-0/Gyki 52895
- 869369-26-6/N-[4-Amino-5-(2,3-difluoro-6-methoxybenzoyl)-2-pyrimidinyl]-1-(methylsulfonyl)-4-piperidinamine monomethanesulfonate
- 86937-03-3/N-Boc-O-(3-Boc-aminopropyl)-L-tyrosine
- 869371-45-9/Methanesulfonamide, N-[3-(aminomethyl)-4-methylphenyl]-N-methyl-
- 869371-61-9/N-(2-(Aminomethyl)-4-methylphenyl)-N-methylmethanesulfonamide
- 869371-69-7/N-(2-(Aminomethyl)-6-methylphenyl)-N-methylmethanesulfonamide
- 869377-50-4/Benzaldehyde, 2-(3,4-dihydro-2,4-dioxo-1(2H)-quinazolinyl)-
- 869377-79-7/(αS)-α-(Difluoromethyl)-benzenemethanamine Hydrochloride
- 869464-89-1/3-(5-sulfanyl-1,3,4-oxadiazol-2-yl)-1lambda6-thiolane-1,1-dione
- 869464-90-4/3H-1,2,4-Triazole-3-thione, 2,4-dihydro-4-(2-propen-1-yl)-5-(tetrahydro-1,1-dioxido-3-thienyl)-
- 869466-88-6/Partially Hydrogenated Jojoba Oil
- 869471-53-4/5-phenyl-2-[(2-thiophen-2-ylacetyl)amino]thiophene-3-carboxamide
- 869472-61-7/Imidazo[1,2-a]pyridine-3-carbonitrile, 2-hydroxy-
- 869472-63-9/2-Propenoic acid, 3-(6-nitro-4H-1,3-benzodioxin-8-yl)-
- 869472-69-5/1H-Pyrrole-2-carboxylic acid, 4-[(diethylamino)sulfonyl]-
- 869472-72-0/4H-1,2,4-Triazole-4-acetic acid, 1,5-dihydro-α-(1-methylethyl)-3-(2-thienyl)-5-thioxo-
- 869472-73-1/3(2H)-Quinazolineacetic acid, 1,4-dihydro-α-(1-methylethyl)-4-oxo-2-thioxo-
- 869472-74-2/1-(3-chloro-4-fluorobenzenesulfonyl)piperidine-4-carboxylic acid
- 869474-87-3/2(1H)-Isoquinolineacetamide, 3,4-dihydro-N-[2-[[[(4-methylphenyl)methyl]amino]carbonyl]phenyl]-
- 869475-97-8/(2E)-3-(2,3-dimethoxyphenyl)-1-(2-methylphenyl)prop-2-en-1-one
- 869482-69-9/3-bromo-7,9-diphenylcyclopenta[a]acenaphthylen-8-one
- 869485-36-9/Dirithromycin EP impurity B
- 869487-78-5/869487-78-5
- 869487-79-6/benzyl ((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)carbamate
- 869488-96-0/trans-Benzyl 3-fluoro-4-hydroxypyrrolidine-1-carboxylate
- 869490-47-1/Gosogliptin Hydrochloride
- 869493-21-0/4-hydroxy-7-isopropyl-6-oxo-N-(3-(piperidin-1-yl)propyl)-6,7-dihydrothieno[2,3-b]pyridine-5-carboxamide
- 869493-47-0/methyl4-hydroxy-7-isopropyl-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carboxylate
- 869493-49-2/3-[4-(trifluoromethyl)piperidin-1-yl]propan-1-amine